Dr. Callaghan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
- University of Iowa Hospitals and ClinicsResidency, Radiation Oncology, 2018 - 2022
- University of Central Florida/HCA Florida Healthcare (Greater Orlando/Osceola)Internship, Transitional Year, 2017 - 2018
- Tulane University School of MedicineClass of 2017, MD
- Tulane School of Public Health and Tropical MedicineMPH, 2013 - 2016
- Tulane School of MedicineMS, Clinical Anatomy, 2013 - 2016
Certifications & Licensure
- MN State Medical License 2022 - 2025
- WI State Medical License 2023 - 2025
- IA State Medical License 2018 - 2022
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Annual Meeting Abstract Travel Award in Biology ASTRO, 2021
- Oral Presentation ASTRO 2021 Conference ASTRO, 2021
- Holman Research Pathway in Radiation Oncology ABR, 2019-2021
- Join now to see all
Publications & Presentations
PubMed
- 25 citationsSystematic Review of Intensity-Modulated Brachytherapy (IMBT): Static and Dynamic Techniques.C.M. Callaghan, Quentin Adams, Ryan T. Flynn, Xiaodong Wu, Weiyu Xu
International Journal of Radiation Oncology, Biology, Physics. 2019-09-01 - 28 citationsOptimizing Advances in Nanoparticle Delivery for Cancer Immunotherapy.Joseph M. Caster, C.M. Callaghan, Steven N. Seyedin, Kelly Henderson, Bo Sun
Advanced Drug Delivery Reviews. 2019-04-01 - 23 citationsBrachytherapy Future DirectionsJ. Adam M. Cunha, Ryan T. Flynn, Cédric Bélanger, C.M. Callaghan, Yusung Kim
Seminars in Radiation Oncology. 2020-01-01
Abstracts/Posters
- Pharmacologic Ascorbate Enhances the Therapeutic Index of ATM-Inhibitor Based Chemoradiation for Colorectal Cancer.Callaghan CM, Abukhiran I, VanRheeden R., Ali MY, Petronek MS, Mapuskar KA, Seyedin SN, Kalen AL, Rodman S, Cullen JJ, Coleman M, Goswami P, Buatti JM, Spitz DR, Allen..., Oral presentation. ASTRO 63rd Annual Conference., 10/26/2021
- Pharmacologic ascorbate enhances the therapeutic index of ATM-inhibitor based chemoradiation for colorectal cancer.Callaghan CM, Seyedin SN, Mapuskar KA, Petronek MS, VanRheeden RV, Rodman SN, Cullen JJ, Darbro BW, Spitz DR, Allen BG, Coleman MC, Goswami P, and Caster JM., ASCO 2021, 6/4/2021
- Utilizing Pharmacologic Ascorbate to Enhance the Therapeutic Index of DNA Repair Inhibitor-Based Chemoradiotherapy for Rectal Cancers.Callaghan CM, Seyedin SN, Mapuskar KA, Petronek MS, VanRheeden RV, Rodman SN, Cullen JJ, Darbro BW, Spitz DR, Allen BG, Coleman MC, Goswami P, and Caster JM., ASTRO 2020, 10/25/2020
- Join now to see all
Lectures
- Pharmacologic Ascorbate Enhances the Therapeutic Index of ATM-Inhibitor Based Chemoradiation for Colorectal CancerOral presentation ASTRO 63rd Annual Conference - 10/26/2021
- Updates in Diagnosis-specific Graded Prognostic Assessments for Brain Metastases.ISTRO 2019 - 10/26/2019
- Systematic review of intensity-modulated brachytherapy (IMBT): static and dynamic techniquesABS Annual Conference 2019 Miami, FL. - 3/16/2019
Grant Support
- Pharmacologic Ascorbate, DNA Repair Inhibitors, and Therapeutic Index of Radiation Therapy in Colorectal CancerRSNA2019–2020
Research History
- Holman Pathway in Radiation Oncology2019 - 2021
Professional Memberships
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: